I don't think the downside is zero at all. $90m of cash and trail assets can't entirely disappear from the balance sheet. The strategic review is there to ensure it doesn't.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025